SCHEMBL4623341

SCHEMBL4623341

CNC1CCN(Cc2cnccn2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WNT1 P04628 1/20 0.42
GSK3B P49841 1/20 0.42
DYRK1A Q13627 1/20 0.42
CXCR3 P49682 1/20 0.40
SCN9A Q15858 1/20 0.40
ROCK2 O75116 5/20 0.40
ROCK1 Q13464 5/20 0.40
CDC42BPB Q9Y5S2 3/20 0.40
TNKS O95271 1/20 0.38
PARP1 P09874 1/20 0.38
TNKS2 Q9H2K2 1/20 0.38
HRH4 Q9H3N8 1/20 0.38
ACKR3 P25106 1/20 0.38
CDC42BPA Q5VT25 2/20 0.37
IKZF2 Q9UKS7 1/20 0.37
SIGMAR1 Q99720 2/20 0.37
CYP2D6 P10635 1/20 0.37
HRH1 P35367 1/20 0.37
OPRM1 P35372 1/20 0.37
TLR9 Q9NR96 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4883824 0.98 WNT1 (0.41) WNT1GSK3BDYRK1ACXCR3SCN9A
SCHEMBL15014498 0.83 ALDH1A1 (0.49) WNT1GSK3BDYRK1ASCN9ATNKS
SCHEMBL12424465 0.80 SCN9A (0.41) WNT1GSK3BDYRK1ASCN9ATNKS
SCHEMBL17289014 0.80 TNKS (0.46) WNT1GSK3BDYRK1ASCN9ATNKS
SCHEMBL22432752 0.80 SCN9A (0.42) WNT1GSK3BDYRK1ASCN9ATNKS
SCHEMBL22547944 0.79 WNT1 (0.37) WNT1GSK3BDYRK1ASCN9AROCK2
SCHEMBL12384434 0.79 SCN9A (0.43) WNT1GSK3BDYRK1ASCN9ATNKS
SCHEMBL22432726 0.79 SCN9A (0.47) WNT1GSK3BDYRK1ASCN9ATNKS
SCHEMBL4621335 0.79 CXCR3 (0.60) CXCR3SIGMAR1CYP2D6HRH1OPRM1
SCHEMBL803082 0.78 SCN9A (0.40) WNT1GSK3BDYRK1ASCN9ATNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101243071-A 2, 4-dianilinopyrimidine derivatives, their preparation, their use as medicaments, pharmaceutical compositions and in particular as IKK inhibitors SANOFI AVENTIS (FR) 2008-08-13 CN disclosed
EP-1904479-A2 NOVEL 2,4-DIANILINOPYRIMIDINE DERIVATIVES, THE PREPARATION THEREOF, THEIR USE AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND, IN PARTICULAR, AS IKK INHIBITORS Sanofi-Aventis (FR) 2008-04-02 EP disclosed
WO-2007006926-A2 NOVEL 2,4-DIANILINOPYRIMIDINE DERIVATIVES, THE PREPARATION THEREOF, THEIR USE AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND, IN PARTICULAR, AS IKK INHIBITORS SANOFI-AVENTIS (FR) 2007-01-18 WO disclosed